Literature DB >> 15850501

Low doses of lithium carbonate reduce melatonin light sensitivity in healthy volunteers.

Karen T Hallam1, James S Olver, Jennifer E Horgan, Caroline McGrath, Trevor R Norman.   

Abstract

Sensitivity of the pineal hormone melatonin to bright light at night has been posited as a putative marker of affective disorders. Research demonstrates melatonin supersensitivity to light in bipolar disorder, however the role that lithium carbonate plays in this response is unclear. This study assessed the effect of lithium on nocturnal melatonin secretion and sensitivity to light in healthy adults. Ten participants, tested on two nights, had blood samples drawn between 20:00 and 02:30 hours. On testing nights participants were exposed to 200 lux of light between 24:00 and 01:00 hours. Participants took 250 mg of lithium daily for 5 d between testing nights. The results indicated that lithium had a significant effect on sensitivity to light but not on overall melatonin synthesis. This finding has implications on the true magnitude of the melatonin light response in people with bipolar disorder and may elucidate possible mechanisms of action of lithium.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15850501     DOI: 10.1017/S1461145704004894

Source DB:  PubMed          Journal:  Int J Neuropsychopharmacol        ISSN: 1461-1457            Impact factor:   5.176


  18 in total

Review 1.  New targets for rapid antidepressant action.

Authors:  Rodrigo Machado-Vieira; Ioline D Henter; Carlos A Zarate
Journal:  Prog Neurobiol       Date:  2015-12-23       Impact factor: 11.685

2.  The SSRI citalopram increases the sensitivity of the human circadian system to light in an acute dose.

Authors:  E M McGlashan; L S Nandam; P Vidafar; D R Mansfield; S M W Rajaratnam; S W Cain
Journal:  Psychopharmacology (Berl)       Date:  2018-09-15       Impact factor: 4.530

Review 3.  Melatonin, circadian rhythms, and the clock genes in bipolar disorder.

Authors:  Sara Dallaspezia; Francesco Benedetti
Journal:  Curr Psychiatry Rep       Date:  2009-12       Impact factor: 5.285

Review 4.  The relationship between bipolar disorder, seasonality, and premenstrual symptoms.

Authors:  Deborah R Kim; Kathryn A Czarkowski; C Neill Epperson
Journal:  Curr Psychiatry Rep       Date:  2011-12       Impact factor: 5.285

Review 5.  Mood, the Circadian System, and Melanopsin Retinal Ganglion Cells.

Authors:  Lorenzo Lazzerini Ospri; Glen Prusky; Samer Hattar
Journal:  Annu Rev Neurosci       Date:  2017-05-17       Impact factor: 12.449

Review 6.  Chronobiology of bipolar disorder: therapeutic implication.

Authors:  Sara Dallaspezia; Francesco Benedetti
Journal:  Curr Psychiatry Rep       Date:  2015-08       Impact factor: 5.285

7.  Increased sensitivity to light-induced melatonin suppression in premenstrual dysphoric disorder.

Authors:  Barbara L Parry; Charles J Meliska; Diane L Sorenson; Ana Lopez; Luis Fernando Martínez; Richard L Hauger; Jeffrey A Elliott
Journal:  Chronobiol Int       Date:  2010-08       Impact factor: 2.877

8.  Melatonin suppression by melanopsin-weighted light in patients with bipolar I disorder compared to healthy controls

Authors:  Philipp Ritter; Falk Wieland; Debra J. Skene; Andrea Pfennig; Maria Weiss; Michael Bauer; Emanuel Severus; Henry Güldner; Cathrin Sauer; Bettina Soltmann; Stefanie Neumann
Journal:  J Psychiatry Neurosci       Date:  2020-03-01       Impact factor: 6.186

9.  The characteristics of sleep in patients with manifest bipolar disorder, subjects at high risk of developing the disease and healthy controls.

Authors:  Philipp S Ritter; Carolin Marx; Natalia Lewtschenko; Steffi Pfeiffer; Karolina Leopold; Michael Bauer; Andrea Pfennig
Journal:  J Neural Transm (Vienna)       Date:  2012-08-18       Impact factor: 3.575

Review 10.  Bipolar disorder: candidate drug targets.

Authors:  Carlos A Zarate; Husseini K Manji
Journal:  Mt Sinai J Med       Date:  2008 May-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.